Navigate to
-
Insurers are using prior authorization and other managed care strategies to control costs associated with the growing number of prescriptions, on- and off-label, for the weight-loss medications
Prime Article: In the News -
Real-world data show higher treatment persistence among patients using Wegovy compared with older weight-loss medications
Prime Article: In the News -
Real-world data show many patients discontinue weight-loss medications within the first year
Prime Article: In the News -
Only around one-third of patients prescribed weight loss drugs such as Novo Nordisk’s blockbuster injection Wegovy continued to take it a year later, according to an analysis shared with CNBC
Prime Article: In the News -
As more and more high-cost therapies, including cell and gene therapies (CGTs), enter the U.S. market, commercial health plans have multiple tools at their disposal to manage these agents
Prime Article: In the News -
cover image for 2026 Medical Pharmacy Trend Report: Part 1 - Payer Survey Packed with insights on real-world management trends for the hottest industry topics Prime Therapeutics...
Prime Article: Research & Publications -
Annual meeting will feature industry research posters and educational sessions
Prime Article: Events -
Abby Kim, PharmD, BCOP, is a senior director, clinical strategy and oncology specialty solutions, shares key takeaways from the American Journal of Managed Care (AJMC) forum, “Bridging evidence and...
Prime Article: Perspectives -
Annual conference features presentations, panels, discussions and networking
Prime Article: Events -
-
New indications for approved traditional drugs - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* zopapogene imadenovec-drba Papzimeos Precigen...
-
AAVRh74var adeno-associated virus serotype Rh74var ABSSSI acute bacterial skin and skin structure infections AChR acetylcholine receptor ADHD attention deficit hyperactivity disorder ALK anaplastic...
-
New indications for approved traditional drugs - 2025 Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* mitomycin intravesical solution Zusduri Urogen...
-
Jan-Apr 2025 (last posted March 24, 2026): — NADAC Public Report Document #1 — NADAC Public Report Document #2 May-Aug 2025 (last posted January 16, 2026): — NADAC Public Report Document #1 — NADAC...
-
Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* cosibelimab-ipdl Unloxcyt Checkpoint Metastatic or locally advanced cutaneous squamous cell carcinoma IV...
-
Generic name Brand name Manufacturer Indication(s) Route of administration Month approved* diazoxide choline Vykat XR Soleno Hyperphagia in Prader-Willi syndrome (≥ 4 years of age) Oral March...
-
publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 Generic Name Brand Name Manufacturer Indication(s) Month Approved*...
-
Traditional drug approvals Glossary Traditional drug approvals - 2026 Vaccine and immunization new approvals - 2026 Configure the table properties New indications for approved biosimilars - 2026...
-
Configure the table properties Cellular and gene therapy and biosimilar approvals Oncology drug approvals - 2026 None Configure the table properties Specialty drug approvals Traditional drug...
-
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax....
-
9 Comprehensive outcomes reporting Insert Link Learn more about cystic fibrosis We support members navigating their cystic fibrosis (CF) with a holistic, customized approach to care. Tab 1 Holistic...
-
Connect care for your members with cancer Home Our solutions Specialty drug management IntegratedRx IntegratedRx - Oncology Reducing the risk of major side effects IntegratedRx® streamlines the...
-
$3,413 Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing strategies, for all lines of business. When...
-
Insert Link Explore Medical Pharmacy Solutions Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing...
-
IntegratedRx – Cystic Fibrosis drives $28,200 in savings annually per utilizing member.¹ Provider has minimal connection to central specialty pharmacy. Footnotes 1 Based on actual claims,...
-
IntegratedRx®– Cystic Fibrosis streamlines the cystic fibrosis treatment pathway with in-house dispensing and a coordinated care team. Oncology Integration is key Connected physician, member and...
-
Discover our value-based contracting solution Support your members with hemophilia We deliver the insights you need on member adherence, program performance and much more with our robust reporting...
-
April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth leading cause of cancer related death.¹ In 2023, approximately 64,050 people were...
-
Concerns about pricing remain prominent, reflecting the continued introduction of high‑cost agents and the expansion of existing therapies into earlier lines of treatment and longer durations of...
-
Nondiscrimination & Languages Prime Therapeutics (Prime) complies with applicable federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability...
-
Tab 1 Holistic support across medical & pharmacy benefit Pharmacy benefit Medical benefit Footnotes 72% Multiple sclerosis is a potentially disabling disease of the brain and spinal cord (central...
-
GuidedHealth can help you save up to $2 per member per month (PMPM).1 1 Prime internal data, 2024; savings specific to health plan, not employer group Home Our solutions Clinical solutions...
-
Heading Example A paragraph is a self-contained unit of a discourse in writing dealing with a particular point or idea. Paragraphs are usually an expected part of formal writing, used to organize...
-
State homepage CMS approval letter Alaska Minnesota State homepage CMS approval letter Michigan State homepage CMS approval letter New Hampshire Attachment B – Catalogue of NMPI participating...
-
NCCN Recommendations for use of immunoglobulin² Intervention CAR T BsAbs Other indications Immunoglobulin replacement After CAR T-cell therapy, regular immune globulin infusions based on clinical...
-
Prime Therapeutics Pharmacy LLC Expires 06/03/2027 Prime Therapeutics Management LLC Expires 08/01/2026 View accreditation Prime Therapeutics Pharmacy LLC Expires 04/18/2028 Tab 1 For your patients...
-
$1 MILLION Contact us to learn more The state estimates they will treat 10 patients with Product X over the next 12 months for a total spend of $10 million. Tie costs to outcomes with VBCs 7,000...
-
Expert Clinical Insights A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that offers access to more than 175...
-
Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey
Prime Article: Stories -
Prime expert shares exciting enhancement to the Medical Pharmacy Trend Report
Prime Article: Perspectives